AbbVie To Switch Track In Alzheimer’s From Tau To Beta-Amyloid

Brain decline and dementia or aging as memory loss concept for brain cancer decay or an Alzheimer's disease with old rusting mechanical gears and cog wheels in the shape of a human head with rust.
AbbVie joins the rush to test beta-amyloid hypothesis in Alzheimer's

More from Earnings

More from Business